Marine polysaccharides for antibiofilm application: A focus on biomedical fields.

Fuente: PubMed
Saved in:
Bibliographic Details
Main Authors: Jeong, Geum-Jae, Khan, Fazlurrahman, Kim, Do-Kyun, Cho, Kyung-Jin, Tabassum, Nazia, Choudhury, Arunabh, Hassan, Md Imtaiyaz, Jung, Won-Kyo, Kim, Hyun-Woo, Kim, Young-Mog
Format: Artículo científico
Language:en
Published: International journal of biological macromolecules 2024
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868266277674418176
author Jeong, Geum-Jae
Khan, Fazlurrahman
Kim, Do-Kyun
Cho, Kyung-Jin
Tabassum, Nazia
Choudhury, Arunabh
Hassan, Md Imtaiyaz
Jung, Won-Kyo
Kim, Hyun-Woo
Kim, Young-Mog
author_facet Jeong, Geum-Jae
Khan, Fazlurrahman
Kim, Do-Kyun
Cho, Kyung-Jin
Tabassum, Nazia
Choudhury, Arunabh
Hassan, Md Imtaiyaz
Jung, Won-Kyo
Kim, Hyun-Woo
Kim, Young-Mog
Jeong, Geum-Jae
Khan, Fazlurrahman
Kim, Do-Kyun
Cho, Kyung-Jin
Tabassum, Nazia
Choudhury, Arunabh
Hassan, Md Imtaiyaz
Jung, Won-Kyo
Kim, Hyun-Woo
Kim, Young-Mog
collection PubMed - marine biology
contents Marine polysaccharides for antibiofilm application: A focus on biomedical fields. Jeong, Geum-Jae Khan, Fazlurrahman Kim, Do-Kyun Cho, Kyung-Jin Tabassum, Nazia Choudhury, Arunabh Hassan, Md Imtaiyaz Jung, Won-Kyo Kim, Hyun-Woo Kim, Young-Mog Biofilms Polysaccharides Aquatic Organisms Humans Animals Anti-Bacterial Agents Biocompatible Materials Microbial pathogens such as bacteria and fungi form biofilms, which represent substantial hurdles in treating human illness owing to their adaptive resistance mechanism to conventional antibiotics. Biofilm may cause persistent infection in a variety of bodily areas, including wounds, oral cavity, and vaginal canal. Using invasive devices such as implants and catheters contributes significantly to developing healthcare-associated infections because they offer an ideal surface for biofilm formation. Marine organisms produce a variety of polysaccharides, which have recently attracted worldwide attention due to their biochemical features, various applications, and advantageous properties such as bioactivity, biodegradability, and biocompatibility. Because of their antimicrobial and antibiofilm features, several polysaccharides such as chitosan, fucoidan, carrageenan, alginate, and hyaluronic acid have been used to treat infected wounds as well as ophthalmic, oral, and vaginal infections. In addition, marine polysaccharides are currently employed as coatings on medical devices and implant materials, alone or in combination with other bioactive substances or nanomaterials, to protect the materials' undertones from microbial contamination. This review discussed the recent advancements in marine polysaccharides and their derivatives as a therapeutic potential against biofilm-associated diseases. The potential obstacles in the scalability of their production, clinical translation, and/or regulatory hurdles have also been discussed.
format Artículo científico
id pubmed_39577534
institution PubMed
language en
publishDate 2024
publisher International journal of biological macromolecules
record_format pubmed
spellingShingle Marine polysaccharides for antibiofilm application: A focus on biomedical fields.
Jeong, Geum-Jae
Khan, Fazlurrahman
Kim, Do-Kyun
Cho, Kyung-Jin
Tabassum, Nazia
Choudhury, Arunabh
Hassan, Md Imtaiyaz
Jung, Won-Kyo
Kim, Hyun-Woo
Kim, Young-Mog
Biofilms
Polysaccharides
Aquatic Organisms
Humans
Animals
Anti-Bacterial Agents
Biocompatible Materials
Marine polysaccharides for antibiofilm application: A focus on biomedical fields. Jeong, Geum-Jae Khan, Fazlurrahman Kim, Do-Kyun Cho, Kyung-Jin Tabassum, Nazia Choudhury, Arunabh Hassan, Md Imtaiyaz Jung, Won-Kyo Kim, Hyun-Woo Kim, Young-Mog Biofilms Polysaccharides Aquatic Organisms Humans Animals Anti-Bacterial Agents Biocompatible Materials Microbial pathogens such as bacteria and fungi form biofilms, which represent substantial hurdles in treating human illness owing to their adaptive resistance mechanism to conventional antibiotics. Biofilm may cause persistent infection in a variety of bodily areas, including wounds, oral cavity, and vaginal canal. Using invasive devices such as implants and catheters contributes significantly to developing healthcare-associated infections because they offer an ideal surface for biofilm formation. Marine organisms produce a variety of polysaccharides, which have recently attracted worldwide attention due to their biochemical features, various applications, and advantageous properties such as bioactivity, biodegradability, and biocompatibility. Because of their antimicrobial and antibiofilm features, several polysaccharides such as chitosan, fucoidan, carrageenan, alginate, and hyaluronic acid have been used to treat infected wounds as well as ophthalmic, oral, and vaginal infections. In addition, marine polysaccharides are currently employed as coatings on medical devices and implant materials, alone or in combination with other bioactive substances or nanomaterials, to protect the materials' undertones from microbial contamination. This review discussed the recent advancements in marine polysaccharides and their derivatives as a therapeutic potential against biofilm-associated diseases. The potential obstacles in the scalability of their production, clinical translation, and/or regulatory hurdles have also been discussed.
title Marine polysaccharides for antibiofilm application: A focus on biomedical fields.
topic Biofilms
Polysaccharides
Aquatic Organisms
Humans
Animals
Anti-Bacterial Agents
Biocompatible Materials
url https://pubmed.ncbi.nlm.nih.gov/39577534/